1. Home
  2. ELME vs HROW Comparison

ELME vs HROW Comparison

Compare ELME & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elme Communities

ELME

Elme Communities

HOLD

Current Price

$17.37

Market Cap

1.5B

Sector

Real Estate

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$47.21

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELME
HROW
Founded
1960
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ELME
HROW
Price
$17.37
$47.21
Analyst Decision
Hold
Strong Buy
Analyst Count
5
8
Target Price
$15.00
$68.86
AVG Volume (30 Days)
1.7M
535.4K
Earning Date
10-23-2025
11-10-2025
Dividend Yield
4.14%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$246,959,000.00
$250,042,000.00
Revenue This Year
N/A
$39.05
Revenue Next Year
N/A
$40.48
P/E Ratio
N/A
N/A
Revenue Growth
3.10
47.83
52 Week Low
$13.95
$20.85
52 Week High
$18.08
$51.30

Technical Indicators

Market Signals
Indicator
ELME
HROW
Relative Strength Index (RSI) 64.36 60.58
Support Level $16.38 $44.48
Resistance Level $17.34 $47.90
Average True Range (ATR) 0.12 2.46
MACD 0.01 0.82
Stochastic Oscillator 80.56 68.13

Price Performance

Historical Comparison
ELME
HROW

About ELME Elme Communities

Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: